Pra (PRAA) Net Margin Growth (3y) (2012 - 2026)
Powered by 
Analysis
Pra (PRAA) Net Margin Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Orix | 44.18 Bn | 44.51 Bn | 4.68 Bn | 2,273.00 |
| 2 | Royalty Pharma | 33.59 Bn | 35.70 Bn | - | -5,319.00 |
| 3 | Royal Gold | 21.14 Bn | 21.00 Bn | 390.45 Mn | 857.00 |
| 4 | OR Royalties | 6.88 Bn | 6.81 Bn | 82.22 Mn | 8,943.00 |
| 5 | Encore Capital | 2.11 Bn | 1.93 Bn | 455.04 Mn | 487.00 |
| 6 | Atlanticus Holdings | 1.41 Bn | 851.50 Mn | 686.46 Mn | -9.00 |
| 7 | Jefferson Capital | 1.18 Bn | 1.16 Bn | - | - |
| 8 | Lufax Holding | 1.04 Bn | -1.23 Bn | - | -1,800.00 |
| 9 | Upbound | 998.67 Mn | 893.37 Mn | 594.84 Mn | 651.00 |
| 10 | Pra | 790.61 Mn | 725.61 Mn | 356.41 Mn | 1,528.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1,528.00 |
| Mar 31, 2026 | 4,477.00 |
| Dec 31, 2025 | 1,011.00 |
| Sep 30, 2025 | -14,094.00 |
| Jun 30, 2025 | 74.00 |
| Mar 31, 2025 | -1,103.00 |
| Dec 31, 2024 | -640.00 |
| Sep 30, 2024 | -363.00 |
| Jun 30, 2024 | -1,237.00 |
| Mar 31, 2024 | -1,678.00 |
| Dec 31, 2023 | -1,603.00 |
| Sep 30, 2023 | -2,162.00 |
| Jun 30, 2023 | -2,182.00 |
| Mar 31, 2023 | -4,358.00 |
| Dec 31, 2022 | -387.00 |
| Sep 30, 2022 | 8.00 |
| Jun 30, 2022 | 635.00 |
| Mar 31, 2022 | 751.00 |
| Dec 31, 2021 | 643.00 |
| Sep 30, 2021 | 835.00 |